FluGen's Incubator/Accelerator Round

FluGen raised a round of funding on , . Investors include MGE Innovation Center.

FluGen is developing a universal influenza vaccine. The REDEE FLU influenza vaccine contains mutations in the M2 gene of the virus. The mutated virus can infect cells, express the entire spectrum of i…

Articles about FluGen's Incubator/Accelerator Round: